Literature DB >> 17133209

Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials.

Maya L Petersen1, Yue Wang, Mark J van der Laan, David R Bangsberg.   

Abstract

Randomized controlled trials of interventions to improve adherence to antiretroviral medications are not always feasible. Marginal structural models (MSM) are a statistical methodology that aims to replicate the findings of randomized controlled trials using observational data. Under the assumption of no unmeasured confounders, 3 MSM estimators are available to estimate the causal effect of an intervention. Two of these estimators, G-computation and inverse probability of treatment weighted (IPTW), can be implemented using standard software. G-computation relies on fitting a multivariable regression of adherence on the intervention and confounders. Thus, it is related to the standard multivariable regression approach to estimating causal effects. In contrast, IPTW relies on fitting a multivariable logistic regression of the intervention on confounders. This article reviews the implementation of these methods, the assumptions underlying them, and interpretation of results. Findings are illustrated with a theoretic data example in which MSM are used to estimate the effect of a behavioral intervention on adherence to antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133209     DOI: 10.1097/01.qai.0000248344.95135.8d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors:  Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal:  Integr Cancer Ther       Date:  2011-09-30       Impact factor: 3.279

2.  Association of tenofovir exposure with kidney disease risk in HIV infection.

Authors:  Rebecca Scherzer; Michelle Estrella; Yongmei Li; Andy I Choi; Steven G Deeks; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

3.  Implementation of G-computation on a simulated data set: demonstration of a causal inference technique.

Authors:  Jonathan M Snowden; Sherri Rose; Kathleen M Mortimer
Journal:  Am J Epidemiol       Date:  2011-03-16       Impact factor: 4.897

4.  Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo.

Authors:  Andrew Edmonds; Marcel Yotebieng; Jean Lusiama; Yori Matumona; Faustin Kitetele; David Nku; Sonia Napravnik; Stephen R Cole; Annelies Van Rie; Frieda Behets
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

5.  Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Authors:  Brittany Barker; Evan Adams; Evan Wood; Thomas Kerr; Kora DeBeck; Huiru Dong; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  AIDS Behav       Date:  2019-05

6.  The Impact of Implementation Fidelity on Mortality Under a CD4-Stratified Timing Strategy for Antiretroviral Therapy in Patients With Tuberculosis.

Authors:  Monita R Patel; Daniel Westreich; Marcel Yotebieng; Mbonze Nana; Joseph J Eron; Frieda Behets; Annelies Van Rie
Journal:  Am J Epidemiol       Date:  2015-03-18       Impact factor: 4.897

Review 7.  Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations.

Authors:  Maya Petersen; Constantin T Yiannoutsos; Amy Justice; Matthias Egger
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

8.  Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study.

Authors:  Mélanie Prague; Daniel Commenges; Jon Michael Gran; Bruno Ledergerber; Jim Young; Hansjakob Furrer; Rodolphe Thiébaut
Journal:  Biometrics       Date:  2016-07-26       Impact factor: 2.571

9.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

10.  The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.

Authors:  Michael Rosenblum; Steven G Deeks; Mark van der Laan; David R Bangsberg
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.